Second row (see Fig. 6, panel β) presents a patient with a WHO III° astrocytoma (MGMT+, IDH1+, LOH1p/19q−) with an ambiguous report concluding that no high-grade recurrence was detected. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).